Study Findings on Parkinson’s Disease Are Outlined in Reports from Herdecke University (Epidemiology of Parkinson’s Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data): Neurodegenerative Diseases and Conditions – Parkinson’s Disease

2025 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Policy and Law Daily -- Fresh data on Neurodegenerative Diseases and Conditions - Parkinson’s Disease are presented in a new report. According to news originating from Witten, Germany, by NewsRx correspondents, research stated, “Parkinson’s disease (PD) is a fast-growing neurodegenerative disease causing a high burden on national health systems. There is a lack of contemporary, reliable epidemiological data for PD in Germany.”

Our news journalists obtained a quote from the research from Herdecke University, “The aim of this study was to estimate the incidence and prevalence of PD in Germany for the years 2016-2021. This is a secondary data analysis of anonymized health claims data from a subset of German statutory health insurances (SHIs) for the years 2016-2021. Data were then extrapolated to represent the full SHI population. From 2016 to 2021, PD prevalence in the study population increased from 494 to 511 patients per 100,000 (p = 0.0067). Incident patients showed no change overall but notably decreased from 2019 to 2020. In contrast, PD prevalence in the extrapolated cohort declined significantly during the same period, dropping from 575 to 501 patients per 100,000 (p < 0.0001). Similarly, PD incidence decreased from 69 to 60 patients per 100,000 (p = 0.0001). PD prevalence increased in the study population but declined in the extrapolated cohort, while incidence remained stable overall in the study population, yet decreased in the extrapolated cohort.”

According to the news editors, the research concluded: “This study provides key insights into the epidemiology of PD in Germany, highlighting the influence of methodology and the need for ongoing monitoring to inform healthcare planning.”

For more information on this research see: Epidemiology of Parkinson’s Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data. Brain and Behavior, 2025;15(11). Brain and Behavior can be contacted at: Wiley, 111 River St, Hoboken, NJ 07030, USA. (Wiley-Blackwell - http://www.wiley.com/; Brain and Behavior - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2157-9032)

The news correspondents report that additional information may be obtained from Gisa Ellrichmann, Faculty of Health, School of Medicine, Chair of Neurology II, Witten, Herdecke University, Witten, Germany. Additional authors for this research include Dirk Woitalla, Stefan Jun Groiss, Stefan Walzer, Lutz-Michael Vollmer, Signe Thiesen-Nash, Sebastian Krenberger, Julia Borchert and Glynn Harrison-Jones.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1002/brb3.71027. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

The publisher’s contact information for the journal Brain and Behavior is: Wiley, 111 River St, Hoboken, NJ 07030, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)